Pharmacogenetics-based AUC prediction model may determine the optimal initial dose of axitinib in renal cell carcinoma
Yoshiaki YamamotoRyouichi TsunedomiYusuke FujitaHiroaki MatsumotoYoshihiko HamamotoShoichi HazamaHiroaki NaganoHideyasu Matsuyama
第77回日本癌学会学術総会